Pierluigi Macchioni
- Rheumatology top 0.2%
- Spondyloarthritis Studies and Treatments 34
- Rheumatoid Arthritis Research and Therapies 32
- Otitis Media and Relapsing Polychondritis 20
- Systemic Lupus Erythematosus Research 19
- Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 26
- Pulmonary and Respiratory Medicine top 0.5%
- Vasculitis and related conditions 53
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis 16
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 17
- Co-authors
- Carlo SalvaraniLuigi BoiardiMariagrazia CatanosoNicolò PipitoneFabrizio CantiniGianluigi BajocchiLia PulsatelliLuca Cimino
- Partner nations
- ItalyUnited KingdomSpain
In The Last Decade
Pierluigi Macchioni
124 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 104
- Rheumatology 2.7k
- Genetics 1.0k
- Pulmonary and Respiratory Medicine 2.5k
- Immunology 883
- Hematology 444
Countries citing papers authored by Pierluigi Macchioni
This map shows the geographic impact of Pierluigi Macchioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierluigi Macchioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierluigi Macchioni more than expected).
Fields of papers citing papers by Pierluigi Macchioni
This network shows the impact of papers produced by Pierluigi Macchioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierluigi Macchioni. The network helps show where Pierluigi Macchioni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierluigi Macchioni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 6 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 36 | |
| 9 | 2018 | 22 | |
| 10 | 2016 | 82 | |
| 11 | Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre. | 2014 | 8 |
| 12 | Serum levels of long pentraxin PTX3 in patients with polymyalgia rheumatica. | 2010 | 14 |
| 13 | 2008 | 121 | |
| 14 | 2008 | 78 | |
| 15 | Frequency of musculoskeletal conditions among patients referred to Italian tertiary rheumatological centers. | 2007 | 6 |
| 16 | 2007 | 15 | |
| 17 | 2006 | 33 | |
| 18 | 2002 | 35 | |
| 19 | 1998 | 20 | |
| 20 | 1989 | 11 |
About Pierluigi Macchioni
Pierluigi Macchioni is a scholar working on Rheumatology, Genetics and Hematology, having authored 128 papers that have together received 4.1k indexed citations. Recurring topics across this work include Vasculitis and related conditions (53 papers), Spondyloarthritis Studies and Treatments (34 papers), Rheumatoid Arthritis Research and Therapies (32 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (26 papers), Otitis Media and Relapsing Polychondritis (20 papers), Systemic Lupus Erythematosus Research (19 papers), Autoimmune and Inflammatory Disorders Research (17 papers) and Psoriasis: Treatment and Pathogenesis (16 papers). The work is most often cited by research in Rheumatology (2.7k citations), Genetics (1.0k citations) and Pulmonary and Respiratory Medicine (2.5k citations). Pierluigi Macchioni has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Carlo Salvarani, Luigi Boiardi, Mariagrazia Catanoso, Nicolò Pipitone, Fabrizio Cantini, Gianluigi Bajocchi, Lia Pulsatelli, Luca Cimino, I Portioli and Riccardo Melicòni.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.